I am a radiation oncologist at Memorial Cancer Institute where I treat patients with all types of cancer. I specialize in image-guided brachytherapy, a type of internal radiation therapy, used to treat gynecological cancers, prostate cancer, head and neck cancers, skin cancer, breast cancer and endobronchial cancers. 

I was drawn to a career in cancer care because it blends science with heart. In oncology, we have an opportunity to make a real difference in someone’s life in their time of need.

At Memorial Cancer Institute, we are like an extended family working closely and collaboratively to ensure that each patient gets the best possible care. We strive to deliver personalized care with a personal touch, providing the support and resources to help you while undergoing treatment and embarking on life after cancer.

In addition to caring for patients, I’m active in several national medical associations, including the American Society of Radiation Oncology (ASTRO), where I've served on the Congressional Relations Subcommittee of the Government Relations Committee.

Hospital Affiliations

• Joe DiMaggio Children's Hospital
• Memorial Hospital Miramar
• Memorial Hospital Pembroke
• Memorial Hospital West
• Memorial Regional Hospital

Gender

• Male

Education

Medical College Of Virginia, 2005

Internships

University Of Washington Medical Center, 2006, Internal Medicine

Residency

Cleveland Clinic Hospital, 2010, Radiation Oncology

Fellowships

UCLA Health System, 2014

Certifications

American Board of Radiology-Radiation Oncology

Publications

Professional Organizations

• American Medical Association
• American Society for Therapeutic Radiation Oncology
• American Brachytherapy Society

Presentations

• ASTRO 2007, ASCO GU Symposium 2008: A Comparison of Biochemical Relapse Free Survival (bRFS) Between Primary Gleason 3 and Primary Gleason 4 for Biopsy Gleason 7 Prostate Cancer. Burdick MJ, Reddy CA, Ciezki JP, Ulchaker J, Angermeier K, Altman A, Chehade N, Mahadevan A, Kupelian PA, Klein EA.
• ASTRO 2008, Chicago Thoracic Symposium 2008: SUVs from Staging FDG- PET Do Not Predict Treatment Outcomes for Early Stage NSCLC Treated with SBRT. Burdick MJ. Stephans KL, Reddy CA, Djemil T, Srinivas SM, Videtic GMM.
• ASTRO 2009, Cleveland Clinic Research Symposium 2009, AMA-RFS 2009, American Radium Society 2010: External Beam Radiotherapy Followed by 90Y Ibritumomab Tiuxetan in Relapsed Bulky Follicular Lymphoma. Burdick MJ, Neumann D, Pohlman B, Reddy CA, Tendulkar R, Macklis RM.